CHADDS FORD, PA — MOBILion Systems, Inc. is set to exhibit at the 73rd Annual American Society for Mass Spectrometry (ASMS) Conference, taking place from June 1–5, 2025, in Baltimore, Maryland. The company will spotlight the impact of its MOBIE® High-Resolution Ion Mobility product and preview its upcoming proteomics system, BILLIE™, which features groundbreaking advancements.
With over 50 abstracts, including oral and poster presentations, independent researchers will demonstrate the MOBIE system’s versatility across critical applications such as pharmaceutical development, chiral molecule analysis, lipidomics, and PFAS research. The presentations highlight the system’s growing adoption and success in enabling innovation within emerging workflows.
At the conference, MOBILion plans to unveil the capabilities of its next-generation BILLIE platform, powered by the company’s novel Parallel Accumulation Mobility Aligned Fragmentation (PAMAF) technology. PAMAF is designed to enhance speed, sensitivity, and selectivity in liquid chromatography–high-resolution mass spectrometry (LC-HRMS) applications, creating a new standard in proteomic analysis.
“ASMS is the ideal venue to highlight the exciting breakthroughs our users are achieving with the MOBIE system, and to share where we are heading with BILLIE,” said Melissa Sherman, Ph.D., CEO of MOBILion Systems. “Our team has been on a journey to improve separation science, holistically. There is nothing more rewarding than seeing our users show to industry peers the characterization boundaries being broken with the MOBIE product. This year is particularly exciting for the MOBILion team because we are also providing a first look of our next product in development. The performance improvements BILLIE will offer through PAMAF represent a true step-change in mass spectrometry workflows allowing researchers to push the boundaries of what’s possible in proteomics and beyond.”
PAMAF enables faster MS/MS fragmentation at over 500 Hz while utilizing nearly 100% of available ions. It eliminates the slow, inefficient quadrupole isolation step found in traditional tandem quadrupole mass spectrometry. This advancement promises faster data acquisition as well as greater sensitivity and accuracy, even with complex biological samples.
“For over two decades, scientists have worked to overcome the speed and sensitivity limitations of traditional MS workflows,” said Daniel DeBord, Ph.D., Chief Technology Officer at MOBILion. “PAMAF enables fragmentation data with dramatically higher signal-to-noise at speeds up to five times faster than conventional systems. We’re excited to showcase this next frontier in proteomics at ASMS.”
Highlights of MOBILion’s Participation at ASMS
Key events featuring MOBILion at the ASMS Conference include a series of breakfast seminars from June 2–4, featuring expert users of MOBIE and PAMAF technology. Highlights include presentations by Dr. Sarah Choyke on PFAS analysis, Dr. Ben Orsburn on single-cell proteomics, and Dr. John R. Yates on its application in N-glycosylation analysis.
Further engagement opportunities include MOBILion’s presence at Booth #434 in the exhibition hall, where attendees can learn more about the advancements transforming LC-MS workflows. The company will also host an exclusive afterparty on June 2 at the Poe Room in the Hilton Baltimore, offering informal networking and celebration..
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.